Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Integra Lifesciences Holdings (IART) Receivables - Net (2016 - 2026)

Integra Lifesciences Holdings' Receivables - Net history spans 17 years, with the latest figure at $278.8 million for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 2.38% to $278.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $278.8 million, a 2.38% increase, with the full-year FY2025 number at $278.8 million, up 2.38% from a year prior.
  • Receivables - Net hit $278.8 million in Q4 2025 for Integra Lifesciences Holdings, up from $262.2 million in the prior quarter.
  • Over the last five years, Receivables - Net for IART hit a ceiling of $284.5 million in Q2 2025 and a floor of $222.2 million in Q3 2021.
  • Historically, Receivables - Net has averaged $251.5 million across 5 years, with a median of $253.2 million in 2023.
  • The widest YoY moves for Receivables - Net: up 28.29% in 2021, down 8.96% in 2021.
  • Tracing IART's Receivables - Net over 5 years: stood at $231.8 million in 2021, then rose by 13.65% to $263.5 million in 2022, then decreased by 1.57% to $259.3 million in 2023, then increased by 5.03% to $272.4 million in 2024, then rose by 2.38% to $278.8 million in 2025.
  • Business Quant data shows Receivables - Net for IART at $278.8 million in Q4 2025, $262.2 million in Q3 2025, and $284.5 million in Q2 2025.